Holdings of Pivotal bioVenture Partners Investment Advisor LLC
12 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 99.1 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 12 | 235.1M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Vaxcyte Inc | 1,372,425 | 79.8M $ | |
| 2 | Evommune Inc | 1,926,943 | 44.3M $ | |
| 3 | Arcutis Biotherapeutics Inc | 1,355,892 | 31.9M $ | |
| 4 | Trevi Therapeutics Inc | 1,553,726 | 18.5M $ | |
| 5 | Immunome Inc | 732,512 | 16M $ | |
| 6 | MapLight Therapeutics Inc | 611,447 | 12.4M $ | |
| 7 | ZENAS BIOPHARMA INC | 591,991 | 11.6M $ | |
| 8 | BioAge Labs Inc | 653,374 | 11.4M $ | |
| 9 | AVALO THERAPEUTICS INC | 295,933 | 4.4M $ | |
| 10 | RALLYBIO CORP | 300,579 | 2.7M $ | |
| 11 | Recursion Pharmaceuticals Inc | 595,518 | 1.8M $ | |
| 12 | BOLT BIOTHERAPEUTICS INC | 42,581 | 172K $ |